Skip to main content
NNOX
NASDAQ Industrial Applications And Services

Nano-X Prices $8M At-The-Market Offering While Flagging Potential Impairment Charges

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.902
Mkt Cap
$69.601M
52W Low
$0.734
52W High
$4.95
52W Position info
23% above low
Off High info
82% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

NNOX sits 23% above its 52-week low of $0.734.

Summary

Nano-X Imaging priced an $8 million registered direct offering at $1.00 per unit, a slight premium to market, while also revealing an ongoing impairment review that could materially impact its Q2 results.


Key Events · Financing and Capital Events · NNOX

  • $8M Registered Direct Offering

    The company sold 8 million units at $1.00 each, with each unit consisting of one ordinary share (or a pre-funded warrant) and a warrant to purchase one additional share at $1.15, exercisable after six months and expiring in five years.

  • Potential Dilution from Warrants

    If exercised, the 8 million warrants would add 8 million shares—representing approximately 11.5% of the current outstanding shares—at an exercise price 27% above the current stock price.

  • Impairment Assessment Initiated

    A comprehensive impairment review of all assets, including goodwill and long-lived assets, has been initiated with an external appraiser; final Q2 results may differ materially from preliminary estimates.

  • Use of Proceeds

    Net proceeds will be used for working capital and general corporate purposes, providing near-term liquidity amid a going-concern warning and a cash balance of $31.4 million as of June 30, 2026.


Analysis · NNOX · Industrial Applications And Services

Already facing a going-concern warning and dwindling cash, Nano-X Imaging is raising $8 million through a registered direct offering priced at $1.00 per unit—a slight premium to the current $0.90 share price. Each unit includes one share (or a pre-funded warrant) and a warrant to buy another share at $1.15. The deal provides immediate runway but introduces potential dilution from 8 million warrants. More concerning is the company's disclosure that it has begun a comprehensive impairment assessment of all assets, including goodwill, which could lead to material write-downs in the upcoming Q2 report. This adds uncertainty to an already distressed financial picture.

At the time of this filing, NNOX was trading at $0.90 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $69.6M. The 52-week trading range was $0.73 to $4.95. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NNOX - Latest Insights

NNOX
Jul 23, 2026, 5:30 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.974
Real-time Price: $0.9474 info
Change: -$0.0266 (-3%) info
Market Cap: $69.601M info
NNOX
Jul 23, 2026, 5:29 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.974
Real-time Price: $0.9474 info
Change: -$0.0266 (-3%) info
Market Cap: $69.601M info
NNOX
Jun 26, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.835749
Real-time Price: $0.9474 info
Change: +$0.111651 (+13%) info
Market Cap: $69.601M info
NNOX
Jun 25, 2026, 8:05 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.52
Real-time Price: $0.9474 info
Change: -$0.5686 (-38%) info
Market Cap: $69.601M info
NNOX
Jun 25, 2026, 8:03 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.49
Real-time Price: $0.9474 info
Change: -$0.5426 (-36%) info
Market Cap: $69.601M info